TipRanks
Go Ultimate55% OFF

Jade Biosciences (JBIO) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Jade101Iga NephropathyPhase IIRecruitingA Study of JADE101 in Participants With Immunoglobulin A NephropathyApr 14, 2026
Jade201Rhematoid ArthritisPhase IRecruitingA Phase 1 Study of JADE201 in Participants With Rheumatoid ArthritisApr 10, 2026―
Jade101Healthy Volunteers (Hv)Phase IRecruitingA Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese ParticipantsApr 06, 2026
Jade101Healthy VolunteersPhase IRecruitingA Phase 1 Study of JADE101 in Healthy ParticipantsJun 27, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Jade Biosciences, Inc. (JBIO) have in its pipeline
Jade Biosciences JBIO is currently developing the following drugs: Jade101, Jade201. These drug candidates are in various stages of clinical development as the company works toward FDA approval.